¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"nerve growth factors"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • great auricular nerve
    Å«±Ó¹ÙÄû½Å°æ, ´ëÀ̰³½Å°æ
  • greater occipital nerve
    Å«µÚÅë¼ö½Å°æ, ´ëÈĵνŰæ
  • greater palatine nerve
    Å«ÀÔõÀå½Å°æ, ´ë±¸°³½Å°æ
  • greater petrosal nerve
    Å«¹ÙÀ§½Å°æ, ´ëÃßü½Å°æ
  • groove for radial nerve
    ³ë½Å°æ°í¶û, ¿ä°ñ½Å°æ±¸
  • gustatory nerve
    ¹Ì°¢½Å°æ
  • hypogastric nerve
    ¾Æ·§¹è½Å°æ, ÇϺ¹½Å°æ
  • hypoglossal nerve
    Çô¹Ø½Å°æ, ¼³ÇϽŰæ
  • histaminergic nerve
    È÷½ºÅ¸¹Î½Å°æ
  • iliohypogastric nerve
    ¾ûµ¢¾Æ·§¹è½Å°æ, Àå°ñÇϺ¹½Å°æ
  • ilioinguinal nerve
    ¾ûµ¢»ô±¼½Å°æ, Àå°ñ¼­Çý½Å°æ
  • incisor nerve
    ¾Õ´Ï½Å°æ, ÀýÄ¡½Å°æ
  • inferior laryngeal nerve
    ¾Æ·¡ÈĵνŰæ, ÇÏÈĵνŰæ
  • inferior rectal nerve
    ¾Æ·¡°ðâÀڽŰæ, ÇÏÁ÷Àå½Å°æ
  • infraorbital nerve
    ´«È®¾Æ·¡½Å°æ, ¾È¿ÍÇϽŰæ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • deep petrosal nerve
    ±íÀº¹ÙÀ§½Å°æ
  • deep temporal nerve
    ±íÀº°üÀڽŰæ
  • depressor nerve
    °¨¾Ð½Å°æ
  • dorsal scapular nerve
    µîÂʾî±ú½Å°æ
  • optic nerve disk
    ½Ã°¢½Å°æ¿ø¹Ý, ½Ã°¢½Å°æÀ¯µÎ
  • efferent nerve
    ³¯½Å°æ
  • efferent nerve fiber
    ³¯½Å°æ¼¶À¯
  • encapsulated nerve terminal
    ÇǸ·½Å°æ¼Òü
  • ethmoidal nerve
    ¹úÁý½Å°æ
  • external nasal nerve
    ¹Ù±ùÄڽŰæ
  • free nerve ending
    ÀÚÀ¯½Å°æÁ¾¸»
  • motor nerve ending
    ¿îµ¿½Å°æÁ¾¸»
  • nerve ending
    ½Å°æÁ¾¸»
  • nerve exhaustion
    ½Å°æ¼ÒÁø
  • sensory nerve ending
    °¨°¢½Å°æÁ¾¸»
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • free nerve ending
    ÀÚÀ¯(í»ë¦)½Å°æÁ¾¸».½Å°æÀ¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve ending
    ÀÚÀ¯½Å°æÁ¾¸».[½Å°æ]À¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸».½Å°æÀ¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸»
  • frontal nerve
    ÀüµÎ½Å°æ(îñÔéãêÌè).
  • frontal nerve
    À̸¶½Å°æ
  • frontal nerve block
    ÀüµÎ½Å°æÂ÷´Ü.
  • genitofemoral nerve
    À½ºÎ³Ò´Ù¸®½Å°æ
  • genitofemoral nerve block
    ¼º±â´ëÅð½Å°æ Â÷´Ü.
  • genitofemoral nerve block
    À½ºÎ´ëÅð½Å°æ Â÷´Ü.
  • genitofemoral nerve<³ª> nervus genitofemoralis
    À½ºÎ´ëÅð½Å°æ(ëäÝ»ÓÞ!! ãêÌè).
  • genitofemoral nerve<³ª> nervus genitofemoralis
    ¼º±â´ëÅð½Å°æ(¼º±â´ëÅð½Å°æ).
  • genu (of facial nerve)
    (¾ó±¼½Å°æ)¹«¸­
  • giant nerve fiber
    °Å´ë½Å°æ¼¶À¯.
  • glaucomatous optic nerve atrophy
    ³ì³»Àå½Ã½Å°æÀ§Ãà.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • maximum stationary phase (of growth)
    (Áõ½Ä)±Ø´ëÁ¤Áö±â(ñòãÖпÓÞïÎò­Ñ¢).
  • membranous bone growth
    ¸·»ó°ñ ¼ºÀå(دßÒÍéà÷íþ).
  • membranous bone growth
    ¸·»ó°ñ¼ºÀå(¡­ßÒÍéà÷íþ)
  • new growth
    ½Å»ý¼º.(º´¸®)½Å»ý¹°(ãæßæÚª).
  • new growth
    ½Å»ý¼º(ãæßæàõ).½Å»ý¹°(ãæßæÚª)
  • occupational growth
    Á÷¾÷Àû ¼ºÀå (ÊÙËøËÛËö).
  • one step growth
    ÀÏ´ÜÁõ½Ä(ìéÓ«ñòãÖ).
  • one step growth curve
    ÀÏ´ÜÁõ½Ä°î¼±(¡­ÍØàÊ).
  • one step growth experiment
    ÀÏ´ÜÁõ½Ä½ÇÇè(¡­ãùúÐ).
  • organotypic growth
    ±â°üÇüÀû ¼ºÀå(ÐïίúþîÜà÷íþ)
  • pathologic growth
    º´Àû¼ºÀå(Ü»îÜà÷íþ)
  • phase, growth
    Áõ½Ä±â
  • physical growth
    ½Åü¹ßÀ°(ãóô÷Û¡ëÀ).
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
  • platelet-derived growth factor(PDGF)
    Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • Mandibular nerve
    ¾Æ·¡ÅνŰæ
    [¿¾ ¿ë¾î] ÇϾǽŰæ
  • Vestibular nerve
    ¾È¶ã½Å°æ
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ
  • Medial pectoral nerve
    ¾ÈÂʰ¡½¿±Ù½Å°æ
    [¿¾ ¿ë¾î] ³»ÃøÈä±Ù½Å°æ
  • Medial pterygoid nerve
    ¾ÈÂʳ¯°³±Ù½Å°æ
    [¿¾ ¿ë¾î] ³»ÃøÀ͵¹±Ù½Å°æ
  • Medial dorsal nerve of the second toe
    ¾ÈÂʵîÂʵѰ¹ß°¡¶ô½Å°æ
    [¿¾ ¿ë¾î] Á¦2Áö³»Ãø¹èÃøÁö½Å°æ
  • Medial dorsal cutaneous nerve
    ¾ÈÂʹߵîÇǺνŰæ
    [¿¾ ¿ë¾î] ³»ÃøÁ·¹èÇǽŰæ
  • Medial plantar nerve
    ¾ÈÂʹ߹ٴڽŰæ
    [¿¾ ¿ë¾î] ³»ÃøÁ·Ã´½Å°æ
  • Medial cutaneous nerve of forearm
    ¾ÈÂʾƷ¡ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ³»ÃøÀü¿ÏÇǽŰæ
  • Medial cutaneous nerve of arm
    ¾ÈÂÊÀ§ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãø»ó¿ÏÇǽŰæ
  • Medial sural cutaneous nerve
    ¾ÈÂÊÀåµýÁöÇǺνŰæ
    [¿¾ ¿ë¾î] ³»Ãøºñº¹ÇǽŰæ
  • Posterior rami [Intercostal nerve]
    ¾Õ°¡Áö [°¥ºñ»çÀ̽Űæ]
    [¿¾ ¿ë¾î] ÀüÁö(´Á°£½Å°æ)
  • Anterior ethmoidal nerve
    ¾Õ¹úÁý½Å°æ
    [¿¾ ¿ë¾î] Àü»ç°ñ½Å°æ
  • Anterior interosseous nerve
    ¾Õ»À»çÀ̽Űæ
    [¿¾ ¿ë¾î] Àü°ñ°£½Å°æ
  • Anterior ampullar nerve
    ¾ÕÆØ´ë½Å°æ
    [¿¾ ¿ë¾î] ÀüÆØ´ëºÎ½Å°æ
  • Superficial peroneal nerve
    ¾èÀºÁ¾¾Æ¸®½Å°æ
    [¿¾ ¿ë¾î] õºñ°ñ½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
ANI acute nerve irritation
anti-PNM Ab anti-peripheral nerve myelin antibody
C1 first cervical nerve; first cervical vertebra; first component of complement
CI first cranial nerve
C2 second cervical nerve; second cervical vertebra; second component of complement
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
CSN Carotid sinus nerve
CT Chorda tympani nerve
CPN Common Peroneal Nerve
CNAP Compound nerve action potential
DPNB Dorsal penile nerve block
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mental nerve branch
    À̽ŰæÁö
  • motor nerve
    ¿îµ¿ ½Å°æ
    ³ú ô¼ö ½Å°æ°è¿¡¼­ °ñ°Ý±Ù¿¡ ¿¬°áµÇ°í ½Åü ¿îµ¿ Á¶ÀýÀ» °üÀåÇÏ´Â ¸»ÃʽŰæ. ³ú¿¡¼­ ¾È±ÙÀ¸·Î ¿¬°áµÇ¾î ÀÖ´Â µ¿¾È½Å°æ, ¼³±Ù¿¡ À̸£´Â ¼³ÇÏ½Å°æ µîÀÌ ÀÖÀ¸¸ç, ô¼ö Àü°¢ ¼¼Æ÷·ÎºÎÅÍ »ó¿Ï, Àü¿Ï, ¼Õ, ¼Õ°¡¶ô µîÀÇ ¼Ò±Ù¿¡ ¿¬°áµÇ¾î ÀÖ´Ù. °¨°¢±â¿¡¼­ ³ú·Î °¡´Â °¨°¢½Å°æ¿¡ ´ëÀÀÇÏ´Â ¸»ÀÌ´Ù. ÀÚÀ²½Å°æ°èÀÇ ¸»ÃʽŰ濡µµ Ç÷°ü ¿îµ¿ ½Å°æ°ú °°ÀÌ ¿îµ¿ ½Å°æÀÇ ¼º°ÝÀ» °¡Áö´Â °ÍÀÌ ÀÖ´Ù. »ç¶÷ÀÇ ¿îµ¿ ½Å°æ¿¡´Â ½Å°æ ¼¶À¯ÀÇ ±½±â°¡ 10~20 mÀÇ °Í°ú 2¡­8 m°¡ Àִµ¥, ±½Àº ÂÊÀ» ¥á¼¶À¯, °¡´Â ÂÊÀ» ¥ã¼¶À¯¶ó°í ÇÑ´Ù. ¥á¼¶À¯´Â ±ÙÀ°À» ¼öÃà½Ã۰í, ¥ã¼¶À¯´Â ±Ù ¼öÃàÀÇ Á¤µµ¸¦ ´À³¢´Â ¼ö¿ë±âÀÎ ±Ù ¹æÃßÀÇ °¨µµ¸¦ Á¶ÀýÇÑ´Ù. ¿¹¸¦ µé¸é, ´Ù¸®ÀÇ ±ÙÀ°À¸·Î °¡´Â ¥á¼¶À¯°¡ ¼Õ»óµÇ¸é ±ÙÀ°ÀÌ ¸¶ºñµÇ¾î ÀϾ ¼ö ¾ø°Ô µÇ´Âµ¥, ¥ã¼¶À¯°¡ ¼Õ»óµÇ¸é ±ÙÀ°Àº ¼öÃàÇÏÁö¸¸ ±× Á¤µµ¸¦ ¾Ë ¼ö ¾øÀ¸¹Ç·Î ¼³ ¼ö´Â À־ ÈçµéÈçµéÇÏ¿© °á±¹Àº ³Ñ¾îÁö°í ¸¸´Ù. ¶Ç, 1°³ÀÇ ¿îµ¿ ½Å°æ ¼¶À¯´Â ¸»´Ü¿¡ °¡¼­ °¡Áö·Î ³ª´©¾îÁö°í ¸î °³ÀÇ ±ÙÀ° ¼¶À¯¸¦ Áö¹èÇÑ´Ù. ´Ù¸®ÀÇ ±ÙÀ°°ú °°ÀÌ Å« ±Ù·ÂÀ» ÇÊ¿ä·Î ÇÏ´Â °÷¿¡¼­´Â 1°³ÀÇ ¿îµ¿ ½Å°æÀÌ 100°³ ÀÌ»óÀÇ ±Ù ¼¶À¯¸¦ Áö¹èÇϰí Àִµ¥, ¾ó±¼À̳ª ¼Õ°¡¶ô ±ÙÀ°°ú °°ÀÌ ¼¶¼¼ÇÑ ¿îµ¿ÀÌ ¿ä±¸µÇ´Â °÷¿¡¼­´Â 1°³ÀÇ ¿îµ¿ ½Å°æÀÌ ¸î °³ÀÇ ±Ù ¼¶À¯¸¦ Áö¹èÇÑ´Ù.
  • motor nerve ending
    ¿îµ¿ ½Å°æ Á¾¸»
  • motor nerve fiber of skeletal muscle
    °ñ°Ý±ÙÀÇ ¿îµ¿ ½Å°æ ´º·±
  • multiple cranial nerve palsy
    ´Ù¹ß¼º ³ú ½Å°æ ¸¶ºñ
  • multipolar nerve cell
    ¹µ ±Ø ½Å°æ ¼¼Æ÷, ´Ù±Ø ½Å°æ ¼¼Æ÷
  • musculocutaneous nerve
    ±ÙÇÇ ½Å°æ
    ¿Ï ½Å°æÃÑ ¿ÜÃø ½Å°æ¼Ó¿¡¼­ »ý°Ü óÀ½¿¡´Â Á¤Áß ½Å°æÀÇ ¿ÜÃø ¸é¿¡ Á¢Çϰí Àִµ¥ Â÷Ãû ¹þ¾î³ª Á¶±¸¿Ï±ÙÀ» ¶Õ°í, À̾ »ó¿Ï±Ù°ú »ó¿ÏÀ̵αٰúÀÇ »çÀÌ¿¡¼­ »ó¿Ï À̵α٠°ÇÀÇ ¿ÜÃø ¸é¿¡ ´ÞÇØ ÁÖ¿Í º¸´Ù À§ÂÊ¿¡¼­ »ó¿Ï±Ù¸·À» ¶Õ°í ÇÇÇÏ·Î ³ª¿Â´Ù. ÀÌ »çÀÌ¿¡ »ó±âÀÇ 3±Ù¿¡ °¡Áö¸¦ ³»¾î Áö¹èÇÑ´Ù. ÁÖ¿Í¿¡¼­ ÇÇÇÏ·Î ³ª¿Â Á¾Áö´Â ¿ÜÃø Àü¿Ï ÇǽŰæÀ¸·Î ºÒ¸®°í Àü¿ÏÀÇ ÀåÃø ¿Ü¹Ý ¹× ÇǺο¡ ºÐÆ÷ÇØ ±× ¸»´ÜÀº ¼ö °üÀý¿¡ ´ÞÇÑ´Ù.
  • mylohyoid nerve
    ÇÏ¾Ç ¼³°ñ±Ù ½Å°æ, ¾Ç¼³°ñ±Ù ½Å°æ
  • nasociliary nerve
    ÄÚ ¼¶¸ðü ½Å°æ, ºñ¸ð¾çü ½Å°æ
    »ïÂ÷½Å°æÀÇ ¾È ½Å°æ¿¡¼­ ±â½ÃÇÏ¿© Àå¸ð¾çü ½Å°æ, ÈÄ»ç°ñ ½Å°æ, Àü»ç°ñ ½Å°æ, ȰÂ÷ÇϽŰæ, ¸ð¾çü ½Å°æÀý°úÀÇ ±³ÅëÁö µîÀÇ ºÐÁö¸¦ ³½´Ù. ÀÏ¹Ý °¨°¢¼º ±â´ÉÀ» °¡Áø´Ù.
  • nasopalatine nerve block
    ºñ ±¸°³ ½Å°æ ¸¶Ãë
  • nerve ablation
    ½Å°æ ÀýÁ¦
  • nerve anastomosis
    ½Å°æ ¹®ÇÕ, ½Å°æ ¹®ÇÕ¼ú
  • nerve block
    ½Å°æ Â÷´Ü, ½Å°æ Â÷´Ü¹ý
  • nerve blocking
    ½Å°æ Â÷´Ü, ½Å°æ Â÷´Ü¹ý
  • nerve cell
    ½Å°æ ¼¼Æ÷
    ´º·±¿¡¼­ µ¹±â¸¦ Á¦¿ÜÇÑ ºÎºÐ. ³ÐÀº Àǹ̷δ ´º·±°ú °°Àº ¶æÀ¸·Î ¾²ÀÌÁö¸¸ Á¼Àº Àǹ̷Π½Å°æ ¼¼Æ÷¸¦ ¼¼Æ÷ü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
growth substance <biology, cell biology> Signal molecules that are involved in the control of cell growth and differentiation.
(12 Dec 1998)
chorionic growth hormone-prolactin human placental lactogen
Rubner's laws of growth The law of constant energy consumption: the rapidity of growth is proportional to the intensity of the metabolic processes, the law of the constant growth quotient: in most young mammals, 24% of the entire food energy, or calories, is utilised for growth; in humans only 5% is utilised.
(05 Mar 2000)
pituitary growth hormone <protein> Hormone (191 amino acids) released by anterior pituitary that stimulates release of somatomedin, thereby causing growth.
(18 Nov 1997)
comb-growth test A test for androgenic activity, based upon the stimulation of comb growth in capons (castrated cockerels) or immature roosters.
Synonym: capon-comb-growth test, cock's comb test.
(05 Mar 2000)
placental growth hormone human placental lactogen
plant growth regulators Any of the hormones produced naturally in plants and active in controlling growth and other functions. There are three primary classes: auxins, cytokinins, and gibberellins.
(12 Dec 1998)
plant growth substances <plant biology> Substances that, at low concentration, influence plant growth and differentiation. Formerly referred to as plant hormones or phytohormones, these terms are now suspect because some aspects of the hormone concept, notably action at a distance from the site of synthesis, do not necessarily apply in plants. Also called plant growth regulators.
The major classes are absicisic acid, auxin, cytokinin, ethylene and gibberellin, others include steroid and phenol derivatives.
(31 Dec 1997)
platelet-derived growth factor <growth factor> The major mitogen in serum for growth in culture of cells of connective tissue origin. It consists of 2 different but homologous polypeptides A and B (~30,000 D) linked by disulphide bonds. Believed to play a role in wound healing.
It is carried in the alpha-granules of platelets and is released when platelets adhere to traumatised tissues. Connective tissue cells near the traumatised region respond by initiating the process of replication.
The B chain is almost identical in sequence to p28sis, the transforming protein of simian sarcoma virus, that can transform only those cells that express receptors for platelet derived growth factor, suggesting that transformation is caused by autocrine stimulation. The receptor is a tyrosine kinase.
Acronym: PDGF
(12 Dec 1998)
multiplicative growth Growth by an increase in the number of cells.
(05 Mar 2000)
contact inhibition of growth See: density dependent inhibition.
(18 Nov 1997)
population growth <epidemiology> Increase, over a specific period of time, in the number of individuals living in a country or region.
(12 Dec 1998)
sarcoma growth factor <growth factor> Polypeptide released by sarcoma cells that promotes the growth of cells by binding to a cell surface receptor, the sarcoma cell is therefore self sufficient and independent of normal growth control.
See: growth factors.
The name is no longer commonly used.
(18 Nov 1997)
heparin binding growth factor <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells.
Synonym: heparin binding growth factor.
Acronym: FGF
(18 Nov 1997)
hepatocyte growth factor <growth factor> Polypeptide mitogen originally shown to cause cell division in hepatocytes.
In the liver, the main sources of hepatocyte growth factor are nonparenchymal cells. It is now clear that hepatocyte growth factor is a mitogen for a number of cell types and it is found in many cells outside the liver, including platelets.
Hepatocyte growth factor is synthesised as a single chain precursor that is proteolytically cleaved to give a heavy chain (70 kD) and a light chain (30 kD) linked by a single disulphide bond. It contains multiple copies of the kringle domain.
However, both the single chain precursor and the two chain forms of hepatocyte growth factor are biologically active and hepatocyte growth factor is generally isolated as a mixture of the two forms. Hepatocyte growth factor also alters cell motility and is now known to be identical to scatter factor.
Acronym: HGF
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á